For many years, the pharmaceutical industry has been in a consolidation phase in which major players merge with or acquire companies to strengthen their market position.
Mergers and acquisitions are often slowed by the challenge of assessing the value and substance of a partner’s digital data, as well as by the time and resources required to integrate large volumes of data.
Given the financial stakes, it is essential for companies to see a return on their investment as quickly as possible. This involves rapidly capitalizing on the knowledge (research projects, etc.) of the acquired companies.
Inquiro’s advanced file collection and analysis functions make it the only tool capable of accelerating the integration of such data.